Kouichi Miura

12PUBLICATIONS
33CO-AUTHORS
Metabolic medicineSocial program evaluationPredictive and prognostic markersNutrigenomics and personalised nutritionCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 27, 2026
Cardiometabolic Factor-Specific Metabolic Signatures in Metabolic Dysfunction-Associated Steatotic Liver Disease: Insights from Non-Targeted Metabolomics.

|Apr 01, 2026
Long-Term Outcomes of Sofosbuvir/Velpatasvir Treatment for Hepatitis C Virus-Related Decompensated Cirrhosis: A Retrospective Multicenter Cohort Study.

Satoru Kakizaki, Tadashi Ikegami, Takeshi Hatanaka

|Feb 25, 2025
Effectiveness of Pemafibrate Dose Escalation on Metabolic Dysfunction-Associated Steatotic Liver Disease Refractory to Standard Dose.

Satoshi Shinozaki, Kouichi Miura, Toshiyuki Tahara

|Nov 27, 2024
Non-Targeted Metabolomics Reveal Apomorphine's Therapeutic Effects and Lysophospholipid Alterations in Steatohepatitis.

Hideo Ogiso, Kouichi Miura, Ryozo Nagai

|Jul 27, 2024
Apomorphine Suppresses the Progression of Steatohepatitis by Inhibiting Ferroptosis.

Hiroshi Maeda, Kouichi Miura, Kenichi Aizawa

|Feb 21, 2024
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence.

Xian-Yang Qin, Yohei Shirakami, Masao Honda

Pageof 2

Frequent Collaborators

3 joint publications

Hitoshi Osaka

2 joint publications

Satoshi Shinozaki

1 joint publications

Hiroaki Okamoto

1 joint publications

Kazuhiko Kotani